Company Description
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
The company’s proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.
The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
Country | China |
Founded | 1998 |
IPO Date | Sep 5, 2024 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 11 |
CEO | Jianfei Zhang |
Contact Details
Address: NET Building, Room 306 Beijing, 100101 China | |
Phone | 86 10 8481 7665 |
Website | ftzy.com.cn |
Stock Details
Ticker Symbol | PTHL |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001970544 |
ISIN Number | KYG713991027 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Jianfei Zhang | Chief Executive Officer and Chairman of the Board |
Zhixin Li | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 15, 2024 | 6-K | Report of foreign issuer |
Sep 9, 2024 | 6-K | Report of foreign issuer |
Sep 6, 2024 | 424B4 | Prospectus |
Sep 4, 2024 | EFFECT | Notice of Effectiveness |
Sep 3, 2024 | CERT | Certification by an exchange approving securities for listing |
Aug 30, 2024 | 8-A12B | Registration of securities |
Aug 5, 2024 | POS EX | Filing |
Jun 18, 2024 | POS AM | Post-Effective amendments for registration statement |
May 3, 2024 | SP 15D2 | Filing |
May 3, 2024 | POS AM | Post-Effective amendments for registration statement |